Who owns BIOLINE RX LIMITED SPONSORED ADR?
- Ticker: BLRX
- CUSIP Number: 09071m304
Tip: Access positions for across all investors
Analyze quarterly positions in Bioline Rx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioline Rx stock
Who bought or sold BIOLINE RX LIMITED SPONSORED ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 70k | $217k | 585% | Jun 2026 |
|
| Renaissance Technologies | 15k | $48k | 100% | Jun 2026 |
|
| Citadel Advisors | 15k | $46k | 100% | Jun 2026 |
|
| Rhumbline Advisers | 2.5k | $7.7k | 5% | Jun 2026 |
|
| Wells Fargo & Company | 2.0k | $6.2k | 14% | Jun 2026 |
|
| Citigroup | 1.7k | $4.0k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 500.00 | $1.6k | -72% | Jun 2026 |
|
| Nemes Rush Group | 250.00 | $780.000000 | 0% | Jun 2026 |
|
| UBS Group | 101.00 | $314.998800 | -81% | Jun 2026 |
|
| Morgan Stanley | 100.00 | $230.000000 | 0% | Mar 2026 |
|
| Goss Wealth Management | 82.00 | $256.004000 | -23% | Jun 2026 |
|
| Advisor Group Holdings | 26.00 | $81.000400 | 0% | Jun 2026 |
|
| SBI Securities | 10.00 | $31.000000 | 100% | Jun 2026 |
|
| Danske Bank A/s | 2.00 | $6.000000 | 0% | Jun 2026 |
|
| Banque Cantonale Vaudoise | 1.00 | $1.0k | 0% | Jun 2026 |
|
Who sold out of Bioline Rx?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Mar 2026 | 11k | $25k |
| Rockefeller Capital Management | Mar 2026 | 12.00 | $27.999600 |